Clinical Trials Browser

Phase 1 × AP 1903 reagent × Tumor-Agnostic × Clear all

NCT01823978 2019-10-08

Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer

Phase 1 Completed

Neoplasm Metastasis